Genetic variants associated with response to anti-CGRP monoclonal antibody therapy in a chronic migraine Han Chinese population.

MLA

An, Yu-Chin, et al. “Genetic Variants Associated with Response to Anti-CGRP Monoclonal Antibody Therapy in a Chronic Migraine Han Chinese Population.” Journal of Headache & Pain, vol. 25, no. 1, Sept. 2024, pp. 1–13. EBSCOhost, https://doi.org/10.1186/s10194-024-01850-y.

APA

An, Y.-C., Hung, K.-S., Liang, C.-S., Tsai, C.-K., Tsai, C.-L., Chen, S.-J., Lin, Y.-K., Lin, G.-Y., Yeh, P.-K., & Yang, F.-C. (2024). Genetic variants associated with response to anti-CGRP monoclonal antibody therapy in a chronic migraine Han Chinese population. Journal of Headache & Pain, 25(1), 1–13. https://doi.org/10.1186/s10194-024-01850-y

Chicago

An, Yu-Chin, Kuo-Sheng Hung, Chih-Sung Liang, Chia-Kuang Tsai, Chia-Lin Tsai, Sy-Jou Chen, Yu-Kai Lin, Guan-Yu Lin, Po-Kuan Yeh, and Fu-Chi Yang. 2024. “Genetic Variants Associated with Response to Anti-CGRP Monoclonal Antibody Therapy in a Chronic Migraine Han Chinese Population.” Journal of Headache & Pain 25 (1): 1–13. doi:10.1186/s10194-024-01850-y.